The immune cells and the inflammatory mediators interleukin (IL)-1, IL-6, and IL-17, and the tumor necrosis factor (TNF)-α are well-studied cytokines that actively contribute to the clinical phenotypes of JIA, such as synovial inflammation and bone resorption [3,4]. The gene discussed is IL6; the disease is juvenile idiopathic arthritis.